Xerostomia after radiotherapy. What matters--mean total dose or dose to each parotid gland?

Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]

Volumn 189, Issue 3, 2013, Pages 216-222

  Tribius, S ^a   Sommer, J ^b   Prosch, C ^b   Bajrovic, A ^b   Muenscher, A ^b   Blessmann, M ^b   Kruell, A ^b   Petersen, C ^b   Todorovic, M ^b   Tennstedt, P ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMORADIOTHERAPY; ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER STAGING; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; HEAD AND NECK TUMOR; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PAROTID GLAND; PATHOLOGY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIATION INJURY; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SURVIVAL; XEROSTOMIA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY, ADJUVANT; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OTORHINOLARYNGOLOGIC NEOPLASMS; PAROTID GLAND; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; XEROSTOMIA;

EID: 84876337905     PISSN: None     EISSN: 1439099X     Source Type: None    
DOI: 10.1007/s00066-012-0257-2     Document Type: Article

References (0)